Proof of Usefulness Report

Lykos Therapeutics

Analysis completed on 2/4/2026

+556
Proof of Usefulness Score
Industry Mainstay

Lykos Therapeutics is a prominent biotech entity (formerly MAPS PBC) with high real-world utility in developing MDMA-assisted therapies for PTSD. While the project has historically raised over $100M and completed Phase 3 trials, the submission itself is of extremely poor quality, containing blatantly false claims regarding consumer reach ('most people have used my product') and vague data. The score balances the entity's high potential and established capital against severe penalties for submission inaccuracies and recent critical regulatory setbacks (FDA rejection in August 2024).

Ready to Compete for $150k+ in Prizes?

Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes

View All Reports

Score Breakdown

Real World Utility+237.5
Audience Reach Impact+70
Technical Innovation+135
Evidence Of Traction+100
Market Timing Relevance+40
Functional Completeness+2.5
Subtotal+585
Usefulness Multiplierx0.95
Final Score+556

Project Details

Project URL
lykospbc.com
Description
Lykos Therapeutics, formerly MAPS Public Benefit Corporation, is a company focused on developing MDMA for potential medicinal use, specifically for treating post-traumatic stress disorder (PTSD). They aim to transform mental healthcare by applying evidence-based research to create investigational psychedelics. Despite facing setbacks with FDA approval, the company continues to pursue developing psychedelic-assisted therapies.

Algorithm Insights

Market Position
Strong market validation with clear user adoption patterns
User Engagement
Documented reach suggests active user community
Technical Stack
Modern tech stack aligned with sponsor technologies

Recommendations to Increase Usefulness Score

Document User Growth

Provide specific metrics on user acquisition and retention rates

Showcase Revenue Model

Detail sustainable monetization strategy and current revenue streams

Expand Evidence Base

Include testimonials, case studies, and third-party validation

Technical Roadmap

Share development milestones and feature completion timeline